RBC Life Sciences Inc (RBCL) financial statements (2021 and earlier)

Company profile

Business Address 2301 CROWN COURT
IRVING, TX 75038
State of Incorp. DE
Fiscal Year End December 31
SIC 519 - Miscellaneous Non-durable Goods (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9213,7463,896
Cash and cash equivalents1,9213,7463,896
Receivables1,286907877
Inventory, net of allowances, customer advances and progress billings4,7995,1425,085
Inventory4,7995,1425,085
Prepaid expense 7
Prepaid expense and other current assets833
Deferred tax assets377430462
Other undisclosed current assets464786 
Total current assets:8,84711,01811,154
Noncurrent Assets
Property, plant and equipment4,6834,1694,488
Intangible assets, net (including goodwill)2,2612,3012,342
Goodwill2,2212,2632,298
Intangible assets, net (excluding goodwill)403844
Other noncurrent assets20445
Prepaid expense and other noncurrent assets30
Other undisclosed noncurrent assets00(1)
Total noncurrent assets:7,1496,5166,860
Other undisclosed assets(0)(0)1
TOTAL ASSETS:15,99617,53418,014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,2801,2401,181
Accounts payable2,310  
Accrued liabilities1,4201,1571,111
Employee-related liabilities468  
Taxes payable748369
Interest and dividends payable7  
Debt230212197
Deferred revenue and credits2,1473,6783,231
Other undisclosed current liabilities(549)1,5251,426
Total current liabilities:6,1076,6556,034
Noncurrent Liabilities
Long-term debt and lease obligation9071,1361,349
Long-term debt, excluding current maturities9071,1361,349
Liabilities, other than long-term debt5567281,117
Deferred tax liabilities, net5567281,117
Total noncurrent liabilities:1,4631,8642,465
Total liabilities:7,5708,5198,499
Stockholders' equity
Stockholders' equity attributable to parent8,4269,0149,515
Common stock2222
Additional paid in capital13,71413,71213,689
Accumulated other comprehensive income127115119
Accumulated deficit(5,417)(4,814)(4,314)
Total stockholders' equity:8,4269,0149,515
TOTAL LIABILITIES AND EQUITY:15,99617,53418,014

Income statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
28,27025,47125,160
Cost of revenue
(Cost of Goods and Services Sold)
(12,632)(13,459)(12,528)
Gross profit:15,63812,01212,632
Operating expenses(16,263)(12,636)(13,096)
Operating loss:(625)(625)(464)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
(220)6640
Interest and debt expense(96)(112)(126)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes220(66)(40)
Loss from continuing operations before income taxes:(721)(736)(590)
Income tax benefit118236228
Net loss available to common stockholders, diluted:(603)(500)(361)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Net loss:(603)(500)(361)
Comprehensive loss:(603)(500)(361)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent12(4)(25)
Comprehensive loss, net of tax, attributable to parent:(591)(504)(386)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: